Application of COH-SR4 in preparation of medicine for preventing and/or treating ischemic heart disease

The invention discloses application of COH-SR4 in preparation of a medicine for preventing and/or treating ischemic heart disease, and relates to the technical field of biomedicine. The research finds that COH-SR4 can improve the cardiac function of a mouse after myocardial ischemia/reperfusion injury, increase ejection fraction and short axis shortening rate and reduce the infarct area of the heart of the mouse; cOH-SR4 is given before modeling, so that the apoptosis and oxidative stress level of myocardial cells after ischemia/reperfusion can be reduced; in addition, COH-SR4 can promote AMPK phosphorylation and up-regulate a nuclear transcription factor erythroid 2 related factor 2 (Nrf2), so that oxidative stress is improved, and ferroptosis is reduced. The invention proves that COH-SR4 can be used for preparing the medicine for preventing and/or treating ischemic heart disease, and has important clinical guiding significance..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 15. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

LI PANGBO [VerfasserIn]
GAO JING [VerfasserIn]
LI HUIHUA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-15, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22

Patentnummer:

CN117224515

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000633887